UPLOAD Filing
Immuneering Corp
Date: Aug. 18, 2025 · CIK: 0001790340 · Accession: 0000000000-25-008697
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289589
Letter
Re: Immuneering Corporation Registration Statement on Form S-3 Filed August 13, 2025 File No. 333-289589 Dear Dr. Benjamin J. Zeskind:
August 18, 2025
Dr. Benjamin J. Zeskind President, Chief Executive Officer and Director Immuneering Corporation 245 Main Street, Second Floor Cambridge, MA 02142
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Wesley C. Holmes, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 18, 2025 Dr. Benjamin J. Zeskind President, Chief Executive Officer and Director Immuneering Corporation 245 Main Street, Second Floor Cambridge, MA 02142 Re: Immuneering Corporation Registration Statement on Form S-3 Filed August 13, 2025 File No. 333-289589 Dear Dr. Benjamin J. Zeskind: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Wesley C. Holmes, Esq. </TEXT> </DOCUMENT>